Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 716 across all filing types
Latest filing 2026-06-08 Environmental & Social …
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Please see annexed enclosure.
Environmental & Social Information Classification · 88% confidence The document is a detailed Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, containing extensive non-financial disclosures on environmental, social, governance practices, sustainability metrics, and stakeholder engagement. It is clearly an ESG-type standalone report, fitting the Environmental & Social Information category rather than a brief announcement or financial statement. Therefore, it should be classified as SR.
2026-06-08 English
Please see annexed enclosure.
Annual Report Classification · 96% confidence The document is headed by a cover letter to stock exchanges under SEBI LODR, stating that the Notice of the 21st AGM and the Integrated Annual Report for FY 2025-26 are enclosed. Immediately thereafter follows the full Integrated Annual Report (covering corporate overview, strategic review, ESG, statutory reports, financial statements, management discussion & analysis, board reports, etc.). This is clearly the company’s complete yearly report, containing substantive financial data, performance highlights, and statutory disclosures. Under our taxonomy, this aligns with an Annual Report (10-K) rather than a simple announcement or proxy filing. FY 2026
2026-06-08 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal Notice convening the 21st Annual General Meeting of Laurus Labs, including the meeting date, venue (VC/OAVM), detailed agenda items for ordinary and special business (adoption of audited financial statements, dividend ratification, director appointments, remuneration approvals, etc.), e-voting schedule, and reference to the explanatory statement under Section 102. It is sent to shareholders to provide information and solicit votes for the AGM. This aligns with the definition of a Proxy Solicitation & Information Statement rather than a presentation or the actual AGM event materials.
2026-06-08 English
Please see annexed enclosure.
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a formal Notice convening the 21st Annual General Meeting (AGM) with detailed agenda items, explanatory statements, voting dates and instructions, and proxy/voting information. It is neither the AGM presentation itself nor the final voting results, but rather the solicitation of votes and provision of information to shareholders ahead of the meeting. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-06-08 English
Please see annexed enclosure.
Report Publication Announcement Classification · 90% confidence The document is a short letter (4,290 characters) submitted under SEBI LODR Regulation 30 to India’s stock exchanges, titled “Sub: Newspaper Publication”. It does not contain the AGM notice or the annual report itself, but merely announces that the newspaper advertisement of the 21st AGM (and the proposed dispatch of the Notice of AGM and Annual Report for FY 2025-26) has been published and is enclosed. Under our “menu vs meal” rule, this is not a report but an announcement of publication. This fits the Report Publication Announcement category (RPA).
2026-06-05 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 82% confidence The document is a regulatory announcement to stock exchanges under SEBI Listing Regulations. It informs that the newspaper advertisement for the upcoming 21st Annual General Meeting (AGM) and dispatch of the Notice of AGM and Annual Report has been published. It does not contain the AGM notice or report itself, but simply announces its publication. Under our taxonomy, this is a Report Publication Announcement (RPA), as it notifies stakeholders of the publication of corporate report materials.
2026-06-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.